Neurogene Inc. (NGNE) Operating income 2016–2025
Neurogene Inc. (NGNE) annual operating income history from SEC filings — each fiscal year as reported.
-$103.3MFY2025 · since FY2016: -$37.6M → -$103.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$103.3M | -25.1% |
| FY2024 | -$82.6M | -48.6% |
| FY2023 | -$55.6M | +1.7% |
| FY2022 | -$56.5M | +6.9% |
| FY2021 | -$60.7M | -80.0% |
| FY2020 | -$33.7M | +52.5% |
| FY2019 | -$71.0M | -117.5% |
| FY2018 | -$32.6M | +36.2% |
| FY2017 | -$51.1M | -35.8% |
| FY2016 | -$37.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NGNE financial trends
NGNE RevenueNGNE Net incomeNGNE Net marginNGNE Gross profitNGNE Gross marginNGNE Operating marginNGNE Operating cash flowNGNE Free cash flowNGNE Capital expendituresNGNE Return on equityNGNE Stock buybacksNGNE Dividends paidNGNE Total assetsNGNE Total liabilitiesNGNE Shareholders’ equityNGNE overview →